These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31864114)
21. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications. Witika BA; Bassey KE; Demana PH; Siwe-Noundou X; Poka MS Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077066 [TBL] [Abstract][Full Text] [Related]
22. The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line. Ugorji OL; Umeh ONC; Agubata CO; Adah D; Obitte NC; Chukwu A Heliyon; 2022 Dec; 8(12):e12369. PubMed ID: 36582708 [TBL] [Abstract][Full Text] [Related]
23. Resveratrol entrapped niosomes as yoghurt additive. Pando D; Beltrán M; Gerone I; Matos M; Pazos C Food Chem; 2015 Mar; 170():281-7. PubMed ID: 25306346 [TBL] [Abstract][Full Text] [Related]
24. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release. Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065 [TBL] [Abstract][Full Text] [Related]
25. Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium salt. Muzzalupo R; Tavano L; Lai F; Picci N Colloids Surf B Biointerfaces; 2014 Nov; 123():207-12. PubMed ID: 25260220 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206 [TBL] [Abstract][Full Text] [Related]
27. PEO-b-PCL grafted niosomes: The cooperativilty of amphiphilic components and their properties in vitro and in vivo. Pippa N; Naziris N; Stellas D; Massala C; Zouliati K; Pispas S; Demetzos C; Forys A; Marcinkowski A; Trzebicka B Colloids Surf B Biointerfaces; 2019 May; 177():338-345. PubMed ID: 30772668 [TBL] [Abstract][Full Text] [Related]
28. Brij Niosomes as Carriers for Sustained Drug Delivery─A Fluorescence-Based Approach to Probe the Niosomal Microenvironment. Sarkar S; De S Langmuir; 2022 Apr; 38(15):4521-4537. PubMed ID: 35377656 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Abdelkader H; Alani AW; Alany RG Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390 [TBL] [Abstract][Full Text] [Related]
30. A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization. Carafa M; Marianecci C; Di Marzio L; Rinaldi F; Meo C; Matricardi P; Alhaique F; Coviello T J Pharm Pharm Sci; 2011; 14(3):336-46. PubMed ID: 21903019 [TBL] [Abstract][Full Text] [Related]
31. Formation of bilayer membrane and niosomes by double-tailed polyglyceryl-type nonionic surfactant. Aramaki K; Yamada J; Tsukijima Y; Maehara T; Aburano D; Sakanishi Y; Kitao K Langmuir; 2015 Oct; 31(39):10664-71. PubMed ID: 26355349 [TBL] [Abstract][Full Text] [Related]
32. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Gupta M; Vaidya B; Mishra N; Vyas SP Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195 [TBL] [Abstract][Full Text] [Related]
33. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization. Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125 [TBL] [Abstract][Full Text] [Related]
34. Stability of luciferase plasmid entrapped in cationic bilayer vesicles. Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170 [TBL] [Abstract][Full Text] [Related]
35. Preparation and Properties of Nonionic Vesicles Prepared with Polyglycerol Fatty Acid Esters Using the Supercritical Carbon Dioxide Reverse Phase Evaporation Method. Yamaguchi S; Kimura Z; Misono T; Tsuchiya K; Sakai K; Abe M; Sakai H J Oleo Sci; 2016; 65(3):201-6. PubMed ID: 26876680 [TBL] [Abstract][Full Text] [Related]
36. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting. Ravouru N; Kondreddy P; Korakanchi D; Haritha M Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098 [TBL] [Abstract][Full Text] [Related]
37. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation. Mohsen AM; AbouSamra MM; ElShebiney SA Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377 [TBL] [Abstract][Full Text] [Related]
38. Optimization and Synthesis of Nano-Niosomes for Encapsulation of Triacontanol by Box-Behnken Design. Solano AAB; Dávila-Ortiz G; de Jesús Perea-Flores M; Martínez-Ayala AL Molecules; 2024 Sep; 29(18):. PubMed ID: 39339416 [TBL] [Abstract][Full Text] [Related]
39. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Mehta SK; Jindal N Colloids Surf B Biointerfaces; 2013 Jan; 101():434-41. PubMed ID: 23010052 [TBL] [Abstract][Full Text] [Related]
40. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery. González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]